GHCC offers long-term investment and support to healthcare companies with annual revenue between $5-$75M and up to $10M in profit. They differentiate themselves by aligning with existing leadership and core principles, focusing on sustainable growth rather than short-term profitability. GHCC's low-leverage, buy-and-hold strategy allows for decision-making that is best for the company and its management. Founded in 1947, GHCC has a strong track record and expertise in operations, value creation, and finance. They primarily invest in home health, hospice, specialty pharmacy, home infusion, physician practice management, and technology-enabled solutions companies.